PureTech Health (PRTC) Income from Non-Controlling Interests (2023 - 2025)
PureTech Health (PRTC) reported Income from Non-Controlling Interests of -$176000.0 for Q2 2025, up 97.52% year-over-year from -$89102.7 in Q2 2024, and up 97.52% quarter-over-quarter from -$7.1 million in Q4 2024.
PureTech Health (PRTC) Income from Non-Controlling Interests (2023 - 2025) Analysis & Trends
PureTech Health (PRTC) has 3 years of Income from Non-Controlling Interests data on file, last reported at -$176000.0 in Q2 2025.
- Income from Non-Controlling Interests for Q2 2025 came in at -$176000.0, up 97.52% year-over-year; the trailing twelve-month figure through Jun 2025 was -$14.9 million (changed N/A YoY), and the FY2025 annual result was -$345000.0, up 94.91% from the prior year.
- Income from Non-Controlling Interests climbed to -$176000.0 in Q2 2025 per PRTC's latest filing, from -$7.1 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at -$176000.0 in Q2 2025 and troughed at -$7.1 million in Q2 2024.
- A 3-year average of -$3.7 million and a median of -$3.8 million in 2023 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests plunged 1202.38% in 2024, then jumped 97.52% in 2025.
- A 3-year view of Income from Non-Controlling Interests shows it stood at -$546000.0 in 2023, then sank by 1202.38% to -$7.1 million in 2024, then jumped by 97.52% to -$176000.0 in 2025.
- Business Quant data shows PRTC's Income from Non-Controlling Interests at -$176000.0 in Q2 2025, -$7.1 million in Q4 2024, and -$7.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -176,000.00 |
| Dec 31, 2024 | -7.11 Mn |
| Jun 30, 2024 | -7.11 Mn |
| Dec 31, 2023 | -546,000.00 |